Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Dydrogesterone vs Vaginal Micronized Progesterone in Menopausal Hormone Therapy
NCT07496294Not yet recruiting
- Sponsor
- Sancaktepe Şehit Prof. Dr. İlhan Varank Eğitim ve Araştırma Hastanesi
- Start
- Apr 2026
- Primary completion
- Oct 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial comparing Oral Dydrogesterone Group with Vaginal Micronized Progesterone Group (2 arms). Primary endpoint: Endometrial Thickness at 12 months. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
dydrogesteroneprogesterone
Beyond the preview
Go deeper on NCT07496294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07496294.